Surface modification of lipid-based nanoparticles
There is a growing interest in the development of lipid-based nanocarriers for multiple
purposes, including the recent increase of these nanocarriers as vaccine components …
purposes, including the recent increase of these nanocarriers as vaccine components …
[HTML][HTML] A review on the latest developments of mesoporous silica nanoparticles as a promising platform for diagnosis and treatment of cancer
F Ahmadi, A Sodagar-Taleghani… - International Journal of …, 2022 - Elsevier
Cancer is the second cause of human mortality after cardiovascular disease around the
globe. Conventional cancer therapies are chemotherapy, radiation, and surgery. In fact, due …
globe. Conventional cancer therapies are chemotherapy, radiation, and surgery. In fact, due …
[HTML][HTML] Surface design of nanocarriers: Key to more efficient oral drug delivery systems
H Spleis, M Sandmeier, V Claus… - Advances in colloid and …, 2023 - Elsevier
As nanocarriers (NCs) can improve the solubility of drugs, prevent their degradation by
gastrointestinal (GI) enzymes and promote their transport across the mucus gel layer and …
gastrointestinal (GI) enzymes and promote their transport across the mucus gel layer and …
Alkaline phosphatase: a reliable endogenous partner for drug delivery and diagnostics
B Le‐Vinh, ZB Akkuş‐Dağdeviren… - Advanced …, 2022 - Wiley Online Library
Since the 1960s the membrane‐bound enzyme alkaline phosphatase (ALP) has been
utilized in drug delivery. As it cleaves phosphate substructures from drugs, auxiliary agents …
utilized in drug delivery. As it cleaves phosphate substructures from drugs, auxiliary agents …
Pteroyl-γ-l-glutamate/Pluronic® F68 modified polymeric micelles loaded with docetaxel for targeted delivery and reduced toxicity
N Rarokar, R Agrawal, S Yadav, P Khedekar… - Journal of Molecular …, 2023 - Elsevier
Targeting the cancerous cells is essential to improve the drug's efficacy and avoid toxicity to
normal cells, which can be achieved by surface functionalizing the nanocarriers like …
normal cells, which can be achieved by surface functionalizing the nanocarriers like …
Nanoemulsion in management of colorectal cancer: challenges and future prospects
P Mohite, T Rajput, R Pandhare, A Sangale, S Singh… - …, 2023 - mdpi.com
The second most significant cause of cancer-related mortality and morbidity in the United
States is colorectal cancer (CRC), the third most diagnosed malignancy. People over 50 …
States is colorectal cancer (CRC), the third most diagnosed malignancy. People over 50 …
Drug permeation enhancement, efficacy, and safety assessment of azelaic acid loaded SNEDDS hydrogel to overcome the treatment barriers of atopic dermatitis
Atopic dermatitis is one of the most widespread chronic inflammatory skin conditions that
can occur at any age, though the prevalence is highest in children. The purpose of the …
can occur at any age, though the prevalence is highest in children. The purpose of the …
Development of a novel colloidal system enhancing the dispersibility of tocopherol nanoparticles in a nanoscale nutraceutical delivery system
S Yakoubi, I Kobayashi, K Uemura… - Colloids and Surfaces A …, 2023 - Elsevier
The aim of this study is to develop a new binary emulsifier system to be used as a surface-
active agent in a nanometric delivery system. The effect of the interaction between gum …
active agent in a nanometric delivery system. The effect of the interaction between gum …
[HTML][HTML] Regulatory status quo and prospects for biosurfactants in pharmaceutical applications
The concept of going 'green'and 'cold'has led to utilizing renewable resources for the
synthesis of microbial biosurfactants that are both patient and eco-friendly. In this review, we …
synthesis of microbial biosurfactants that are both patient and eco-friendly. In this review, we …
Expanding opportunities to engineer mucosal vaccination with biomaterials
HF Haddad, EF Roe, JH Collier - Biomaterials Science, 2023 - pubs.rsc.org
Mucosal vaccines are receiving increasing interest both for protecting against infectious
diseases and for inducing therapeutic immune responses to treat non-infectious diseases …
diseases and for inducing therapeutic immune responses to treat non-infectious diseases …